| Stage | MDLN | % of rev | SARO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.9B | 100.00% | $1.6B | 100.00% | MDLN ×4.91 |
| Gross profit | $1.9B | 24.50% | $269M | 16.80% | MDLN +7.7pp |
| Operating income | $500M | 6.36% | $168M | 10.53% | SARO +4.2pp |
| Pre-tax income | $386M | 4.91% | $127M | 7.95% | SARO +3.0pp |
| Net income | $318M | 4.05% | $97M | 6.08% | SARO +2.0pp |
| Stage | MDLN | SARO | Gap · A − B |
|---|---|---|---|
| Revenue | $7.9B100.00% | $1.6B100.00% | MDLN ×4.91 |
| Gross profit | 24.50%$1.9B | 16.80%$269M | MDLN +7.7pp |
| Operating income | 6.36%$500M | 10.53%$168M | SARO +4.2pp |
| Pre-tax income | 4.91%$386M | 7.95%$127M | SARO +3.0pp |
| Net income |
| 4.05%$318M |
| 6.08%$97M |
| SARO +2.0pp |
No shared counterparties.